Skip to main content
Top
Published in: Sleep and Breathing 3/2013

01-09-2013 | Original Article

Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy

Authors: Regina Monteiro, João Bento, Miguel R. Gonçalves, Tiago Pinto, João Carlos Winck

Published in: Sleep and Breathing | Issue 3/2013

Login to get access

Abstract

Background

Dystrophia myotonica (DM) is the most frequent adult-onset muscular dystrophy. Type 1 is caused by the cytosine–thymine–guanine (CTG) repeat expansion in the DM protein kinase gene. Respiratory muscle weakness and altered central ventilatory control lead to hypercapnia and lung volume restriction.

Purpose

This study aims to review the respiratory involvement in DM patients and study its relation with genetics.

Methods

Retrospective study of patients with DM referred for respiratory assessment was made. Noninvasive ventilation (NIV) was considered to daytime hypercapnia or symptoms of nocturnal hypoventilation.

Results

Forty-two consecutive patients (37.9 ± 13.6 years) were evaluated. Mean CTG length was 642.8 ± 439.2 repeats. In the first evaluation, mean forced vital capacity (FVC) was 74.4 ± 20.2 %, maximal expiratory pressure (MEP) 35 ± 16 %, maximal inspiratory pressure 52 ± 23 %, peak cough flow (PCF) 327.3 ± 97.7 L/min, arterial pressure of oxygen 79.7 ± 11.3 mmHg, arterial pressure of carbon dioxide 45.5 ± 6.2 mmHg, overnight minimal peripheral oxygen saturation (SpO2) 79.6 ± 11.6 %, and apnea–hypopnea index 13.9 ± 9.9. CTG length was found to be related with MEP (r = −0.67; p = 0.001) and SpO2 (r = −0.37; p = 0.039). NIV was started in 25 patients. Ventilated patients had lower FVC (2.19 to 3.21 L; p < 0.001) and PCF (285.3 to 388.5 L/min; p = 0.003) and more CTG repeats (826.6 to 388.5 repeats; p = 0.02). NIV compliance was poor in seven patients (28 %) and related with hypercapnia (r = 0.87; p = 0.002) and inspiratory positive airway pressure setting (r = 0.65; p = 0.009). Ventilation improved symptoms and nocturnal hypoventilation. Comparing the first and last evaluations, only PCF was significantly lower (275.0 to 310.8 L/min; p = 0.019).

Conclusions

Ventilatory insufficiency is very common in patients with DM and CTG length may be useful to predict it. Prolonged NIV improves symptoms, nocturnal hypoventilation and maintains daily blood gases. Routine evaluation of PCF should not be forgotten and assisted coughing training provided.
Literature
1.
go back to reference Mc Kim A, Road J, Avendano M, Abdool S, Côté F, Duguid N, Fraser J, Maltais F, Morrison DL, O’Connell C, Petrof BJ, Rimmer K, Skomro R (2011) Home medical ventilation: a Canadian thoracic society clinical practice guideline. Can Respir J 18(4):197–215 Mc Kim A, Road J, Avendano M, Abdool S, Côté F, Duguid N, Fraser J, Maltais F, Morrison DL, O’Connell C, Petrof BJ, Rimmer K, Skomro R (2011) Home medical ventilation: a Canadian thoracic society clinical practice guideline. Can Respir J 18(4):197–215
2.
go back to reference Siciliano G, Manca ML, Gennarelli M, Angelini C, Rucchi A, Iudice A, Miorin M, Mostacciuolo ML (2001) Epidemiology of myotonic dystrophy in Italy: re-appraisal after genetic diagnosis. Clin Genet 59:344–349PubMedCrossRef Siciliano G, Manca ML, Gennarelli M, Angelini C, Rucchi A, Iudice A, Miorin M, Mostacciuolo ML (2001) Epidemiology of myotonic dystrophy in Italy: re-appraisal after genetic diagnosis. Clin Genet 59:344–349PubMedCrossRef
3.
go back to reference Huang CC, Kuo HC (2005) Myotonic dystrophies. Chang Gung Med J 28:517–526PubMed Huang CC, Kuo HC (2005) Myotonic dystrophies. Chang Gung Med J 28:517–526PubMed
4.
go back to reference Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G (2000) Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 57:74–82PubMedCrossRef Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G (2000) Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 57:74–82PubMedCrossRef
5.
go back to reference Bégin P, Mathieu J, Almirall J, Grassino A (1997) Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 156:133–139PubMedCrossRef Bégin P, Mathieu J, Almirall J, Grassino A (1997) Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 156:133–139PubMedCrossRef
6.
go back to reference Ugalde V, Walsh S, Abresch RT, Bonekat HW, Breslin E (2001) Respiratory abdominal muscle recruitment and chest wall motion in myotonic muscular dystrophy. J Appl Physiol 91:395–407PubMed Ugalde V, Walsh S, Abresch RT, Bonekat HW, Breslin E (2001) Respiratory abdominal muscle recruitment and chest wall motion in myotonic muscular dystrophy. J Appl Physiol 91:395–407PubMed
7.
go back to reference Bach JR, Kang SW (2000) Disorders of ventilation: weakness, stiffness and mobilization. Chest 117(2):301–303PubMedCrossRef Bach JR, Kang SW (2000) Disorders of ventilation: weakness, stiffness and mobilization. Chest 117(2):301–303PubMedCrossRef
8.
go back to reference Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2009) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14:19–24PubMedCrossRef Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2009) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14:19–24PubMedCrossRef
9.
go back to reference Ward S, Chatwin M, Heather S, Simonds AK (2005) Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60:1019–1024PubMedCrossRef Ward S, Chatwin M, Heather S, Simonds AK (2005) Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60:1019–1024PubMedCrossRef
10.
go back to reference Mathieu J, Allard P, Potvin L, Prévost C, Bégin P (1999) A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52:1658–1662PubMedCrossRef Mathieu J, Allard P, Potvin L, Prévost C, Bégin P (1999) A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52:1658–1662PubMedCrossRef
11.
go back to reference Tzeng AC, Bach JR (2000) Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 118:1390–1396PubMedCrossRef Tzeng AC, Bach JR (2000) Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 118:1390–1396PubMedCrossRef
12.
go back to reference Annane D, Orlikowski D, Chevret S, Chevrolet JC, Raphael JC (2007) Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD001914 Annane D, Orlikowski D, Chevret S, Chevrolet JC, Raphael JC (2007) Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD001914
13.
go back to reference Bach JR (2004) Management of patients with neuromuscular disease. Hanley & Belfus, Philadelphia Bach JR (2004) Management of patients with neuromuscular disease. Hanley & Belfus, Philadelphia
14.
go back to reference Bach JC, Gonçalves M (2006) Pulmonary rehabilitation in neuromuscular disorders and spinal cord injury. Rev Port Pneumol 12(1):27–44 Bach JC, Gonçalves M (2006) Pulmonary rehabilitation in neuromuscular disorders and spinal cord injury. Rev Port Pneumol 12(1):27–44
15.
go back to reference Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Med (Baltimore) 90(4):262–268CrossRef Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Med (Baltimore) 90(4):262–268CrossRef
16.
go back to reference Lunteren EV, Kaminski HJ (1999) Disorders of sleep and breathing during sleep in neuromuscular disease. Sleep and Breathing 3(1):23–30PubMedCrossRef Lunteren EV, Kaminski HJ (1999) Disorders of sleep and breathing during sleep in neuromuscular disease. Sleep and Breathing 3(1):23–30PubMedCrossRef
17.
go back to reference Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121:459–464PubMedCrossRef Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121:459–464PubMedCrossRef
18.
go back to reference Bach JR (2007) Avoiding respiratory failure in neuromuscular disease: why is it not done? Am J Phys Med Rehabil 86:222–224PubMedCrossRef Bach JR (2007) Avoiding respiratory failure in neuromuscular disease: why is it not done? Am J Phys Med Rehabil 86:222–224PubMedCrossRef
Metadata
Title
Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy
Authors
Regina Monteiro
João Bento
Miguel R. Gonçalves
Tiago Pinto
João Carlos Winck
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-013-0807-6

Other articles of this Issue 3/2013

Sleep and Breathing 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.